BCM
KBIO

Bridgeway Capital Management’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Bridgeway Capital Management’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9,611
Closed -$133K – 1575
2014
Q4 		$133K Hold
9,611
– – ﹤0.01% 1358
2014
Q3 		$119K Buy
9,611
+7,448
+344% +$103K ﹤0.01% 1407
2014
Q2 		$39K Buy
+2,163
New +$37K ﹤0.01% 1425

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bridgeway Capital Management's KBIO Position: Q1 2015 in Review

Bridgeway Capital Management sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2015, closing a stake of 9,611 shares — an estimated $133K sold.

Bridgeway Capital Management first reported a position in KBIO in Q2 2014 and held it in 3 quarters. The position peaked at $133K in Q4 2014. 24 funds tracked by Wall St. Rank hold KBIO as of Q1 2015.

  • Bridgeway Capital Management reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2015 after selling out during the quarter.
  • Bridgeway Capital Management sold 9,611 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2015, an estimated $133K.
  • Bridgeway Capital Management first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2014 and held it in 3 quarters.
  • Bridgeway Capital Management's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $133K in Q4 2014.
  • 24 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2015.

Based on Bridgeway Capital Management's 13F filing for Q1 2015, filed 15 May 2015.